|Bid||286.44 x 300|
|Ask||288.49 x 100|
|Day's Range||288.07 - 291.04|
|52 Week Range||240.30 - 303.74|
|PE Ratio (TTM)||-25.33|
|Expense Ratio (net)||0.47%|
In 2016, Amgen’s (AMGN) Neulasta generated revenues close to $4.6 billion, which was a slight drop from its 2015 net sales of ~$4.7 billion.
Shares of Alexion Pharmaceuticals (ALXN) have been hammered the past two days after its new CEO cleaned house. But has it fallen too far? Investors, it seems, worry that the decision to replace much of ...
Alexion’s management shake-up continues as four executives, including its CFO, exit the company.